Antibiotic Therapy for Bronchitis
Introduction to Antibiotic Therapy
- The American College of Physicians recommends initiating antibiotic therapy with amoxicillin-clavulanate as first-line treatment for bronchitis persisting beyond 15 days with fever, as this duration strongly suggests bacterial superinfection rather than a self-limited viral illness 1
- Bronchitis lasting more than 15 days with persistent fever is not typical of acute viral bronchitis, which usually resolves within 7-10 days 1
- Fever persisting beyond 3 days strongly suggests bacterial superinfection or progression to pneumonia, according to the Infectious Diseases Society of America 2, 3, 1
Diagnosis and Assessment
- A focused pulmonary examination should be performed to distinguish bronchitis from pneumonia, with normal lung auscultation supporting bronchitis and focal findings suggesting pneumonia, as recommended by the American Thoracic Society 2, 4
- A chest X-ray should be considered if the clinical examination is equivocal or the patient appears ill, to confirm parenchymal involvement indicative of pneumonia, according to the European Respiratory Society 2
Antibiotic Regimens
- Amoxicillin-clavulanate is the recommended first-line therapy for bronchitis with prolonged symptoms and fever, providing coverage against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, as suggested by the American Academy of Family Physicians 1
- The duration of treatment should be 5-8 days, as recommended by the Infectious Diseases Society of America 2, 4
- Alternative options, such as second-generation cephalosporins or macrolides, may be considered if amoxicillin-clavulanate is contraindicated, according to the American College of Chest Physicians 1, 2
Target Pathogens and Monitoring
- Antibiotic choice must cover Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, as recommended by the Centers for Disease Control and Prevention 1
- Fever should resolve within 2-3 days after initiating antibiotics, and clinical reassessment should be performed after 2-3 days of treatment, according to the American Academy of Family Physicians 3, 1
- Cough may persist longer than fever and should not be used as the sole indicator of treatment failure, as suggested by the European Respiratory Society 1
Special Considerations
- For patients with underlying chronic obstructive pulmonary disease (COPD) or chronic bronchitis, antibiotics are indicated if ≥2 of 3 Anthonisen criteria are present, according to the Global Initiative for Chronic Obstructive Lung Disease 3, 1
- For COPD patients with FEV1 ≥35%, amoxicillin alone may be sufficient for infrequent exacerbations, while broader spectrum coverage with amoxicillin-clavulanate or fluoroquinolones is preferred for patients with FEV1 <35% or frequent exacerbations, as recommended by the American Thoracic Society 3